Dyadic International, Inc. (DYAI)
NASDAQ: DYAI · Real-Time Price · USD
0.3802
+0.0192 (5.32%)
At close: Oct 30, 2026, 4:00 PM EDT
0.3933
+0.0131 (3.45%)
After-hours: Oct 30, 2026, 7:53 PM EDT
Dyadic International Market Cap
Dyadic International has a market cap or net worth of $13.85 million as of October 30, 2026. It is the 39,423rd most valuable company in the world and the 5,403rd biggest in the United States. Its market cap has decreased by 65.19% in one year.
Market Cap
13.85M
Enterprise Value
15.79M
1-Year Change
-65.19%
Global Rank
Country Rank
#5,403 United States
Category
ChartMarket Cap Chart
Since April 18, 2019, Dyadic International's market cap has decreased from $94.80M to $13.85M, a decrease of -85.39%. That is a compound annual growth rate of -22.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 13.80M | -59.41% |
| Dec 31, 2025 | 34.00M | -34.36% |
| Dec 31, 2024 | 51.80M | 11.64% |
| Dec 29, 2023 | 46.40M | 32.19% |
| Dec 30, 2022 | 35.10M | -72.34% |
| Dec 31, 2021 | 126.90M | -14.20% |
| Dec 31, 2020 | 147.90M | 4.89% |
| Dec 31, 2019 | 141.00M | 48.73% |
| Apr 18, 2019 | 94.80M | - |
View and export this data all the way back to 2019. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Karyopharm Therapeutics | 15.02M |
| Radiopharm Theranostics | 14.77M |
| NewcelX | 14.73M |
| Citius Pharmaceuticals | 14.36M |
| Allarity Therapeutics | 13.85M |
| Daré Bioscience | 13.76M |
| AEON Biopharma | 13.67M |
| BioCardia | 13.03M |